Tearing Back Pain with a Raised Troponin and a Creatinine of 1.9
A 64-year-old man is brought in 90 minutes after the sudden onset of severe tearing pain between the shoulder blades while lifting a box. He is diaphoretic and restless. Blood pressure is 188/102 mmHg in the right arm and 164/96 mmHg in the left; heart rate 96 and regular. Radial and femoral pulses are symmetric, and the neurologic examination is normal. Chest radiograph shows a widened mediastinum. The ECG has nonspecific ST-T changes in the inferior leads, and high-sensitivity troponin is 0.09 ng/mL (upper limit of normal 0.04). Creatinine is 1.9 mg/dL against a documented baseline of 1.1. He has had no prior cardiac or aortic surgery and no previous contrast reaction. The CT scanner is free now; transesophageal echocardiography would require calling in a technician, a two-hour delay.
1. Before any imaging, what is your pharmacologic plan, in what order, and to what numeric targets? Explain why the order is not interchangeable.
Read the worked answer
Analgesia, then rate control, then pressure control - never the reverse.
- Fentanyl 25–50 mcg IV first. Pain and fear drive sympathetic outflow; treating them lowers heart rate and dP/dt before any drug is drawn up.
- Beta-blockade to a heart rate under 60. Esmolol bolus 500 mcg/kg followed by 50–200 mcg/kg/min, or labetalol 20 mg IV every 10 minutes. This is the load-bearing step: it reduces the shear force (dP/dt) that propagates the intimal tear.
- Vasodilator only after rate control, to a systolic blood pressure of 100–120 mmHg. Nicardipine 5 mg/hr titrated is a reasonable choice.
Why the order matters: giving a pure vasodilator first drops pressure but triggers reflex tachycardia and a rise in dP/dt, which can extend the dissection or rupture it. Hydralazine is a poor choice here for exactly this reason - unpredictable, reflex tachycardia. Nitroprusside as a single agent carries the same hazard.
What to hold: no aspirin, no heparin, no antiplatelet loading, no thrombolytics until dissection is excluded. If this is a type A dissection with coronary ostial involvement, a loading dose of aspirin or a heparin bolus is a catastrophic error. Document the hold in the chart so the cath lab or a covering clinician does not give it for you.
The target is a patient who is calm, at a heart rate in the 50s, and systolic around 110 before he enters the scanner.
2. Which imaging study do you choose, and how do you justify it given a creatinine of 1.9? What are the limitations of the alternative?
Read the worked answer
Choose CT angiography of the chest, abdomen, and pelvis now. Do not wait two hours for transesophageal echocardiography, and do not delay for the creatinine.
Reasoning on the kidney: the risk of contrast-associated nephropathy is real but small, is largely reversible, and is measured against a disease with an hourly mortality in type A dissection. There is no creatinine threshold below which CTA becomes the wrong test when dissection is the question. Do not give a fluid bolus purely to protect the kidney - this patient is hypertensive and volume loading will raise his pressure. Proceed, and document the shared reasoning.
Why CTA first: sensitivity and specificity near 99% and 98%, it images the entire aorta in seconds, it defines the intimal flap, the false lumen, branch-vessel involvement, and the extent of any malperfusion - all of which the surgeon needs. It also excludes pulmonary embolism and other causes of tearing chest pain.
Limitations of TEE: it is excellent for the ascending aorta and can be done at the bedside in an unstable patient, but it is operator-dependent, has a blind spot in the distal ascending aorta and proximal arch, is poor for branch vessels and for the descending aorta below the diaphragm, and requires sedation in a hemodynamically fragile patient. Its main role here is as a rescue study if the patient deteriorates before or during transport, or if CTA is equivocal.
If the scan shows a type A dissection, the answer is the operating room, not a discussion about creatinine.
3. The troponin is mildly elevated and there are inferior ST-T changes. Does that push you toward acute coronary syndrome and away from dissection? What changes in management if dissection is confirmed?
Read the worked answer
No. A positive troponin does not exclude dissection, and here it may actually support it.
Roughly a quarter to a third of aortic dissections have an elevated troponin, from three mechanisms: coronary ostial involvement by the flap, global demand ischemia from shock or severe hypertension, and coexisting coronary disease in a vascular patient. Inferior ST-T changes in this particular patient are a red flag rather than a reassurance - the right coronary artery arises near the ascending aorta, and inferior ischemia in the setting of tearing pain can mean the flap is occluding the right coronary ostium. That converts a type A dissection into a surgical emergency with an even shorter clock.
What changes if dissection is confirmed:
- Antiplatelet and anticoagulant therapy is absolutely contraindicated. No aspirin, no heparin, no glycoprotein inhibitors, no thrombolysis - any of these can cause fatal hemorrhage into the pericardium or pleural space.
- A type A goes to immediate cardiothoracic surgery; type B is managed medically unless there is malperfusion, rupture, rapid expansion, or refractory pain or hypertension.
- If troponin is elevated with a confirmed dissection and the patient is hemodynamically stable, that does not trigger a cath lab visit. Coronary involvement is dealt with at surgery.
What changes if dissection is excluded and ACS is confirmed: then the troponin and ST changes become the primary problem and standard ACS therapy resumes. The diagnostic sequence, not the biomarker, decides the treatment.